Clinical Trial Update: Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer

View source ↗

Summary

A Baylor Research Institute-led clinical trial evaluating DNA methylation as an early-detection marker for high-grade serous ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: Baylor Research Institute | Conditions: Epithelial Ovarian Cancer | Status: COMPLETED